News for Imugene Limited (IMU.AX)

Good Afternoon and welcome to HotCopper Highlights wrapping up Week 21 of the year, I’m Jon Davidson. In this segment we look...

**media[582591]**

Good afternoon and welcome to HotCopper’s Market Close for Thursday, I’m Jonathon Davidson.It was another better-looking day for the bourse as the XJO closed above 7,900 points.

The ASX has been trading flat at around 7,864 points. Financials has…

Johns Lyng Group has seen a sharp selloff after it was confirmed the repairer would be removed from the ASX 200 when the index reshuffles.

The ASX200 has been up 0.5% at 8,582 points. The Aussie index…

The Aussie bourse has defied morning expectations for the second time in…

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing…

The ASX 200 is expected to open 0.07% lower at 8,185 points,…

Precision BioSciences stock hits 52-week low at $4.12

Precision Biosciences CFO buys $10,036 in common stock

With more than seven million users moving through HotCopper forums every year,…

We reveal the most watched and discussed stocks on HotCopper for 2024 and bring you expert analysis on IPO activity, themes, and stocks.

Precision BioSciences stock hits 52-week low at $6.4

Precision BioSciences stock hits 52-week low at $7.94

Investors reacted with disappointment to the latest Chinese stimulus measures released on the weekend.

Mineral Resources has agreed to sell its two oil and gas exploration permits in the Perth Basin to Gina Rinehart's Hancock Prospecting.

Precision BioSciences begins clinical trial for hepatitis B cure

Precision BioSciences files for gene editing trial